• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Innovación y acceso: ¿fisión o fusión? Entrevista a la Dra. Kristina M. Lybecker, profesora asociada de Economía del Colorado College

07/06/2016 by Guest contributor for Intellectual Property Watch Leave a Comment

Tomando como referencia el trabajo del Grupo de Alto Nivel de las Naciones Unidas sobre el Acceso a los Medicamentos, esta serie de artículos patrocinados invita a expertos en la materia a expresar sus puntos de vista sobre las políticas que respaldan con mayor eficacia la formulación de soluciones que respondan a los principales desafíos de las sociedades, y sobre cómo los entornos propicios para la implantación de políticas, incluidas las relativas a los sistemas de propiedad intelectual, influyen en el desarrollo y el caudal de nuevas tecnologías y servicios en diferentes sectores, campos tecnológicos y territorios. Las opiniones expresadas en los artículos son las de los autores. A continuación se presenta una entrevista a la Dra. Kristina M. Lybecker, profesora asociada de Economía del Colorado College, en Colorado Springs.

Filed Under: Features, IP Policies, Themes, Venues, Español, Health & IP, Innovation/ R&D, Paid Content, Patents/Designs/Trade Secrets, WHO Tagged With: IFPMA

Innovación y acceso: ¿Fisión o fusión? Entrevista a Tim Wilsdon, vicepresidente de CRA

07/06/2016 by Guest contributor for Intellectual Property Watch Leave a Comment

Tomando como referencia el trabajo del Grupo de Alto Nivel de las Naciones Unidas sobre el Acceso a los Medicamentos, esta serie de artículos patrocinados invita a expertos en la materia a expresar sus puntos de vista sobre las políticas que respaldan con mayor eficacia la formulación de soluciones que respondan a los principales desafíos de las sociedades, y sobre cómo los entornos propicios para la implantación de políticas, incluidas las relativas a los sistemas de propiedad intelectual, influyen en el desarrollo y el caudal de nuevas tecnologías y servicios en diferentes sectores, campos tecnológicos y territorios. Las opiniones expresadas en los artículos son las de los autores. A continuación, presentamos la entrevista a Tim Wilsdon, vicepresidente de CRA.

Filed Under: Features, IP Policies, Language, Themes, Venues, Español, Health & IP, Innovation/ R&D, Paid Content, Patents/Designs/Trade Secrets, WHO Tagged With: IFPMA

Innovation And Access: Fission Or Fusion? Interview With Dr. Kristina M. Lybecker, Associate Professor Of Economics At Colorado College

02/06/2016 by Guest contributor for Intellectual Property Watch 1 Comment

In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with Dr. Kristina M. Lybecker, Associate Professor of Economics at Colorado College in Colorado Springs (US).

Filed Under: Features, IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Paid Content, Patents/Designs/Trade Secrets, United Nations - other, WHO Tagged With: IFPMA

Innovation et accès : fission ou fusion ? Entretien avec David Taylor, Professeur en Politique Pharmaceutique et de Santé Publique à l’UCL (University College London)

30/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment

Dans le sillage du Groupe de Haut Niveau des Nations Unies sur l’accès aux médicaments (UN High-Level Panel on Access to Medicines) cette série d’articles sponsorisés convie des experts à donner leur point de vue sur les politiques les mieux à même de favoriser l’élaboration de solutions aux plus importants enjeux sociétaux, ainsi que sur la manière dont un cadre réglementaire favorable –y compris les systèmes de protection de la propriété intellectuelle – influence le développement et la diffusion de nouvelles technologies et de nouveaux services au sein de différents secteurs, domaines technologiques et juridictions. Les opinions exprimées dans ces articles n’engagent que leurs auteurs.

Filed Under: Features, IP Policies, Language, Themes, Venues, Français, Health & IP, Innovation/ R&D, Paid Content, Patents/Designs/Trade Secrets, United Nations - other, WHO Tagged With: IFPMA

Innovación y acceso: ¿fisión o fusión? Entrevista a David Taylor, profesor de Políticas Farmacéuticas y de Salud Pública del University College de Londres

30/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment

Tomando como referencia el trabajo del Grupo de Alto Nivel de las Naciones Unidas sobre el Acceso a los Medicamentos (UN High-Level Panel on Access to Medicines), esta serie de artículos patrocinados invita a expertos en la materia a expresar sus puntos de vista sobre las políticas que respaldan con mayor eficacia la formulación de soluciones que respondan a los principales desafíos de las sociedades, y sobre cómo los entornos propicios para la implantación de políticas, incluidas las relativas a los sistemas de propiedad intelectual, influyen en el desarrollo y el caudal de nuevas tecnologías y servicios en diferentes sectores, campos tecnológicos y territorios. Las opiniones expresadas en los artículos son las del autor.

Filed Under: Features, IP Policies, Language, Themes, Venues, Español, Health & IP, Innovation/ R&D, Paid Content, Patents/Designs/Trade Secrets, United Nations - other, WHO Tagged With: IFPMA

Innovation And Access: Fission Or Fusion? Interview With Tim Wilsdon, CRA Vice President

25/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment

In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with Tim Wilsdon, Vice President, CRA.

Filed Under: Features, IP Policies, Language, Themes, English, Health & IP, Innovation/ R&D, Paid Content, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer Tagged With: IFPMA

Innovation And Access: Fission Or Fusion? Interview with David Taylor, Professor of Pharmaceutical and Public Health Policy, University College London, UK

18/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment

In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with David Taylor, Professor of Pharmaceutical and Public Health Policy, University College London, UK.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Paid Content, Patents/Designs/Trade Secrets, United Nations - other, WHO Tagged With: IFPMA

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting